The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

Ithaka US Growth Strategy highlighted stocks like DexCom, Inc. (NASDAQ:DXCM), in the third quarter 2024 investor letter. DexCom, Inc. (NASDAQ:DXCM) is a medical device company that develops and ...

Please verify your email address. Ultrasonic sensors provide a more accurate fingerprint scan when compared to traditional optical scanners, but they're also more expensive. Goodix's under-display ...

DexCom concluded the third quarter of 2024 on a positive note, with earnings and revenues surpassing expectations. Key drivers included significant contributions from the Sensor segment and robust ...

DexCom, Inc. DXCM reported third-quarter 2024 ... The broader S&P 500 index has moved up 21.6% in the same period. Sensor and other revenues (96% of total revenues) increased 9% on a year-over ...

Every study in these AID systems has been done with the DexCom sensor. So there aren't any head-to-head studies. They've all been run with DexCom, at least with our pump partners, and that's the ...

Dexcom Chief Commercial Officer Teri Lawver will leave the ... Abbott plans to launch another over-the-counter sensor specifically for people with Type 2 diabetes, but has yet to disclose a timeline.

All products and services featured are independently selected by our editors. However, when you buy something through our retail links, we may earn an affiliate commission. Feng shui is a popular ...

DexCom will likely make significant headway in its addressable market in the next five years. The company should also increase its reach by launching new products and entering new countries ...